11 – 20 of 253
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Pre-asthma : a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1—allergic asthma
(
- Contribution to journal › Scientific review
-
Mark
Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma
2023) In Allergy: European Journal of Allergy and Clinical Immunology(
- Contribution to journal › Article
-
Mark
Preterm or early term birth and long-term risk of asthma into midadulthood : A national cohort and cosibling study
(
- Contribution to journal › Article
-
Mark
Asthma in the era of COVID-19
(
- Contribution to journal › Article
-
Mark
A EUFOREA comment on a lost comorbidity of asthma
(
- Contribution to journal › Letter
-
Mark
Multidisciplinary approaches to identifying and managing global airways disease : Expert recommendations based on qualitative discussions
(
- Contribution to journal › Article
-
Mark
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma : An EAACI position paper
(
- Contribution to journal › Article
-
Mark
Impact of Inititing Biologics in Patients With Severe Asthma on Long-term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
(
- Contribution to journal › Article
-
Mark
Eosinophils and tissue remodeling : Relevance to airway disease
(
- Contribution to journal › Scientific review
-
Mark
EUFOREA summit in Brussels 2023 : inspiring the future of allergy & respiratory care
(
- Contribution to journal › Article